Novocure and US Oncology Research Announce Collaboration on PANOVA-3 Trial for Patients with Advanced Pancreatic Cancer
ST. HELIER, JERSEY, U.K. and THE WOODLANDS, TEXAS, U.S. (August 15, 2018) – Novocure (NASDAQ: NVCR) and US Oncology Research […]
ST. HELIER, JERSEY, U.K. and THE WOODLANDS, TEXAS, U.S. (August 15, 2018) – Novocure (NASDAQ: NVCR) and US Oncology Research […]
Chicago, Illinois (August 6, 2018) – Illinois Cancer Specialists (ICS), an affiliate of The US Oncology Network (The Network), announced […]
SAN FRANCISCO—July 31, 2018—McKesson Corporation (NYSE:MCK) today announced that Brian S. Tyler, Ph.D., has been appointed president and chief operating […]
SAN FRANCISCO—July 31, 2018—McKesson Corporation (NYSE:MCK) today announced that Brian S. Tyler, Ph.D., has been appointed president and chief operating […]
Revenues of $52.6 billion for the first quarter, up 3% year over year.First-quarter GAAP loss per diluted share from continuing […]
CARY, N.C. (July 23, 2018) —Biologics, Inc., a McKesson Specialty Health oncology, neurology and complex care pharmacy services company, has […]
The Woodlands, Texas (July 17, 2018) — The US Oncology Network (The Network) announced the appointment of Marcus Neubauer, M.D., as its […]
LAS VEGAS, July 9, 2018 – McKesson Corporation today kicked off McKesson ideaShare 2018, an annual interactive forum for community […]
The Woodlands, Texas (July 9, 2018)—The US Oncology Network (The Network) announced the appointment of Loren Rourke, M.D., M.H.C.M., as […]
The Woodlands, Texas (July 9, 2018)—The US Oncology Network (The Network) announced the appointment of Loren Rourke, M.D., M.H.C.M., as […]